Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001720032 | SCV000517346 | likely benign | not provided | 2019-01-10 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000872110 | SCV001013878 | benign | Holocarboxylase synthetase deficiency | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002521560 | SCV003552756 | likely benign | Inborn genetic diseases | 2022-01-07 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV003959888 | SCV004772591 | benign | HLCS-related disorder | 2019-11-22 | criteria provided, single submitter | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |